Do analysts prefer CTEC or TSTL?

ConvaTec Group presently has a consensus price target of GBX 306, suggesting a potential upside of 35.40%. Given ConvaTec Group's stronger consensus rating and higher probable upside, analysts plainly believe ConvaTec Group is more favorable than Tristel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ConvaTec Group 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Tristel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation and earnings, CTEC or TSTL?

ConvaTec Group has higher revenue and earnings than Tristel. ConvaTec Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ConvaTec Group £2.49B 1.77 £188.35M £8.60 26.28 Tristel £49.54M 4.15 £6.54M £16.24 26.39

ConvaTec Group (CTEC) Competitors

GBX 226 +0.40 (+0.18%)

As of 08/21/2026 12:13 PM Eastern

Compare

CTEC vs. SN, AMS, NIOX, TSTL, and EKF

Should you buy ConvaTec Group stock or one of its competitors? ConvaTec Group's main competitors and comparable companies include Smith & Nephew (SN), Advanced Medical Solutions Group (AMS), NIOX Group (NIOX), Tristel (TSTL), and EKF Diagnostics (EKF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does ConvaTec Group compare to Smith & Nephew?

ConvaTec Group (LON:CTEC) and Smith & Nephew (LON:SN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

Smith & Nephew has higher revenue and earnings than ConvaTec Group. ConvaTec Group is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ConvaTec Group	£2.49B	1.77	£188.35M	£8.60	26.28
Smith & Nephew	£7.08B	1.66	£382.79M	£27.77	38.51

ConvaTec Group presently has a consensus target price of GBX 306, indicating a potential upside of 35.40%. Smith & Nephew has a consensus target price of GBX 1,310, indicating a potential upside of 22.49%. Given ConvaTec Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe ConvaTec Group is more favorable than Smith & Nephew.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Smith & Nephew	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.0%. Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.7%. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ConvaTec Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

68.4% of ConvaTec Group shares are owned by institutional investors. Comparatively, 62.2% of Smith & Nephew shares are owned by institutional investors. 1.0% of ConvaTec Group shares are owned by company insiders. Comparatively, 0.2% of Smith & Nephew shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Smith & Nephew had 5 more articles in the media than ConvaTec Group. MarketBeat recorded 5 mentions for Smith & Nephew and 0 mentions for ConvaTec Group. Smith & Nephew's average media sentiment score of 0.17 beat ConvaTec Group's score of 0.00 indicating that Smith & Nephew is being referred to more favorably in the news media.

Company	Overall Sentiment
ConvaTec Group	Neutral
Smith & Nephew	Neutral

Smith & Nephew has a net margin of 10.08% compared to ConvaTec Group's net margin of 4.99%. Smith & Nephew's return on equity of 12.25% beat ConvaTec Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ConvaTec Group	4.99%	8.40%	5.01%
Smith & Nephew	10.08%	12.25%	4.51%

ConvaTec Group has a beta of 0.765, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Smith & Nephew has a beta of 0.688, suggesting that its share price is 31% less volatile than the broader market.

Summary

ConvaTec Group beats Smith & Nephew on 10 of the 18 factors compared between the two stocks.

How does ConvaTec Group compare to Advanced Medical Solutions Group?

Advanced Medical Solutions Group (LON:AMS) and ConvaTec Group (LON:CTEC) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

22.7% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 68.4% of ConvaTec Group shares are owned by institutional investors. 4.0% of Advanced Medical Solutions Group shares are owned by insiders. Comparatively, 1.0% of ConvaTec Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Advanced Medical Solutions Group's average media sentiment score of 0.00 equaled ConvaTec Group'saverage media sentiment score.

Company	Overall Sentiment
Advanced Medical Solutions Group	Neutral
ConvaTec Group	Neutral

ConvaTec Group has a net margin of 4.99% compared to Advanced Medical Solutions Group's net margin of 4.35%. ConvaTec Group's return on equity of 8.40% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	4.35%	3.87%	2.35%
ConvaTec Group	4.99%	8.40%	5.01%

Advanced Medical Solutions Group has a beta of 0.704, suggesting that its share price is 30% less volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.765, suggesting that its share price is 24% less volatile than the broader market.

ConvaTec Group has higher revenue and earnings than Advanced Medical Solutions Group. ConvaTec Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£228.94M	2.68	£11.22M	£4.52	62.28
ConvaTec Group	£2.49B	1.77	£188.35M	£8.60	26.28

Advanced Medical Solutions Group presently has a consensus price target of GBX 270.25, indicating a potential downside of 4.00%. ConvaTec Group has a consensus price target of GBX 306, indicating a potential upside of 35.40%. Given ConvaTec Group's stronger consensus rating and higher probable upside, analysts plainly believe ConvaTec Group is more favorable than Advanced Medical Solutions Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.0%. ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.0%. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

ConvaTec Group beats Advanced Medical Solutions Group on 12 of the 16 factors compared between the two stocks.

How does ConvaTec Group compare to NIOX Group?

ConvaTec Group (LON:CTEC) and NIOX Group (LON:NIOX) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

NIOX Group has a net margin of 14.37% compared to ConvaTec Group's net margin of 4.99%. NIOX Group's return on equity of 10.14% beat ConvaTec Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ConvaTec Group	4.99%	8.40%	5.01%
NIOX Group	14.37%	10.14%	3.95%

68.4% of ConvaTec Group shares are owned by institutional investors. Comparatively, 7.6% of NIOX Group shares are owned by institutional investors. 1.0% of ConvaTec Group shares are owned by company insiders. Comparatively, 5.1% of NIOX Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.0%. NIOX Group pays an annual dividend of GBX 1.25 per share and has a dividend yield of 1.8%. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NIOX Group pays out 76.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

NIOX Group has lower revenue, but higher earnings than ConvaTec Group. ConvaTec Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ConvaTec Group	£2.49B	1.77	£188.35M	£8.60	26.28
NIOX Group	£48.70M	5.93	£995.88M	£1.64	41.83

ConvaTec Group presently has a consensus target price of GBX 306, indicating a potential upside of 35.40%. NIOX Group has a consensus target price of GBX 86, indicating a potential upside of 25.36%. Given ConvaTec Group's higher probable upside, analysts plainly believe ConvaTec Group is more favorable than NIOX Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, ConvaTec Group's average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score.

Company	Overall Sentiment
ConvaTec Group	Neutral
NIOX Group	Neutral

ConvaTec Group has a beta of 0.765, indicating that its stock price is 24% less volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market.

Summary

NIOX Group beats ConvaTec Group on 9 of the 16 factors compared between the two stocks.

How does ConvaTec Group compare to Tristel?

ConvaTec Group (LON:CTEC) and Tristel (LON:TSTL) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

ConvaTec Group has a beta of 0.765, indicating that its share price is 24% less volatile than the broader market. Comparatively, Tristel has a beta of 0.346, indicating that its share price is 65% less volatile than the broader market.

ConvaTec Group has higher revenue and earnings than Tristel. ConvaTec Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ConvaTec Group	£2.49B	1.77	£188.35M	£8.60	26.28
Tristel	£49.54M	4.15	£6.54M	£16.24	26.39

ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.0%. Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.3%. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Tristel pays out 87.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Tristel has a net margin of 15.88% compared to ConvaTec Group's net margin of 4.99%. Tristel's return on equity of 23.64% beat ConvaTec Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ConvaTec Group	4.99%	8.40%	5.01%
Tristel	15.88%	23.64%	9.89%

68.4% of ConvaTec Group shares are owned by institutional investors. Comparatively, 22.5% of Tristel shares are owned by institutional investors. 1.0% of ConvaTec Group shares are owned by insiders. Comparatively, 21.0% of Tristel shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

ConvaTec Group presently has a consensus price target of GBX 306, suggesting a potential upside of 35.40%. Given ConvaTec Group's stronger consensus rating and higher probable upside, analysts plainly believe ConvaTec Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Tristel	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, ConvaTec Group's average media sentiment score of 0.00 equaled Tristel'saverage media sentiment score.

Company	Overall Sentiment
ConvaTec Group	Neutral
Tristel	Neutral

Summary

ConvaTec Group and Tristel tied by winning 8 of the 16 factors compared between the two stocks.

How does ConvaTec Group compare to EKF Diagnostics?

ConvaTec Group (LON:CTEC) and EKF Diagnostics (LON:EKF) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

In the previous week, EKF Diagnostics had 2 more articles in the media than ConvaTec Group. MarketBeat recorded 2 mentions for EKF Diagnostics and 0 mentions for ConvaTec Group. EKF Diagnostics' average media sentiment score of 0.34 beat ConvaTec Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media.

Company	Overall Sentiment
ConvaTec Group	Neutral
EKF Diagnostics	Neutral

ConvaTec Group presently has a consensus target price of GBX 306, indicating a potential upside of 35.40%. EKF Diagnostics has a consensus target price of GBX 35, indicating a potential upside of 37.80%. Given EKF Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe EKF Diagnostics is more favorable than ConvaTec Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

ConvaTec Group has a net margin of 4.99% compared to EKF Diagnostics' net margin of 4.12%. ConvaTec Group's return on equity of 8.40% beat EKF Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ConvaTec Group	4.99%	8.40%	5.01%
EKF Diagnostics	4.12%	3.01%	5.27%

ConvaTec Group has higher revenue and earnings than EKF Diagnostics. ConvaTec Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ConvaTec Group	£2.49B	1.77	£188.35M	£8.60	26.28
EKF Diagnostics	£51.56M	2.12	£4.68M	£0.47	54.04

68.4% of ConvaTec Group shares are owned by institutional investors. Comparatively, 22.2% of EKF Diagnostics shares are owned by institutional investors. 1.0% of ConvaTec Group shares are owned by company insiders. Comparatively, 40.0% of EKF Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

ConvaTec Group has a beta of 0.765, meaning that its stock price is 24% less volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.5, meaning that its stock price is 50% less volatile than the broader market.

Summary

ConvaTec Group and EKF Diagnostics tied by winning 8 of the 16 factors compared between the two stocks.

Get ConvaTec Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CTEC vs. The Competition

Export

Metric	ConvaTec Group	Healthcare Equipment & Supplies Industry	Healthcare Sector	LON Exchange
Market Cap	£4.40B	£6.02B	£7.37B	£2.54B
Dividend Yield	2.45%	1.74%	2.53%	6.17%
P/E Ratio	26.28	26.67	272.60	367.57
Price / Sales	1.77	71.61	624.33	83,481.74
Price / Cash	17.01	33.24	78.62	27.89
Price / Book	2.82	6.23	13.05	7.19
Net Income	£188.35M	£150.07M	£3.47B	£5.89B
7 Day Performance	-1.57%	0.69%	2.09%	0.30%
1 Month Performance	6.38%	8.91%	6.64%	3.31%
1 Year Performance	-6.67%	8.07%	25.02%	22.13%

ConvaTec Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CTEC ConvaTec Group	4.4118 of 5 stars	GBX 226 +0.2%	GBX 306 +35.4%	-6.7%	£4.40B	£2.49B	26.28	10,000
SN Smith & Nephew	4.2304 of 5 stars	GBX 1,110.50 +2.1%	GBX 1,310 +18.0%	-22.8%	£12.17B	£7.08B	39.98	18,452	High Trading Volume
AMS Advanced Medical Solutions Group	1.1004 of 5 stars	GBX 281.52 +0.2%	GBX 270.25 -4.0%	+35.3%	£611.47M	£228.94M	62.28	10	High Trading Volume
NIOX NIOX Group	2.5572 of 5 stars	GBX 68 +0.3%	GBX 86 +26.5%	-1.4%	£283.66M	£48.70M	41.46	92	Gap Down
TSTL Tristel	N/A	GBX 420.60 -1.0%	N/A	+17.4%	£204.10M	£49.54M	25.90	208

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:CTEC) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ConvaTec Group (CTEC) Competitors

CTEC vs. SN, AMS, NIOX, TSTL, and EKF

How does ConvaTec Group compare to Smith & Nephew?

Summary

How does ConvaTec Group compare to Advanced Medical Solutions Group?

Summary

How does ConvaTec Group compare to NIOX Group?

Summary

How does ConvaTec Group compare to Tristel?

Summary

How does ConvaTec Group compare to EKF Diagnostics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEC vs. The Competition

ConvaTec Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ConvaTec Group (CTEC) Competitors

CTEC vs. SN, AMS, NIOX, TSTL, and EKF

How does ConvaTec Group compare to Smith & Nephew?

Which has higher valuation & earnings, CTEC or SN?

Do analysts recommend CTEC or SN?

Is CTEC or SN a better dividend stock?

Do insiders & institutionals have more ownership in CTEC or SN?

Does the media favor CTEC or SN?

Is CTEC or SN more profitable?

Which has more volatility and risk, CTEC or SN?

Summary

How does ConvaTec Group compare to Advanced Medical Solutions Group?

Do institutionals and insiders hold more shares of AMS or CTEC?

Does the media refer more to AMS or CTEC?

Is AMS or CTEC more profitable?

Which has more risk & volatility, AMS or CTEC?

Which has better valuation & earnings, AMS or CTEC?

Do analysts rate AMS or CTEC?

Is AMS or CTEC a better dividend stock?

Summary

How does ConvaTec Group compare to NIOX Group?

Is CTEC or NIOX more profitable?

Do institutionals & insiders have more ownership in CTEC or NIOX?

Is CTEC or NIOX a better dividend stock?

Which has better earnings & valuation, CTEC or NIOX?

Do analysts recommend CTEC or NIOX?

Does the media favor CTEC or NIOX?

Which has more risk & volatility, CTEC or NIOX?

Summary

How does ConvaTec Group compare to Tristel?

Which has more risk and volatility, CTEC or TSTL?

Which has stronger valuation and earnings, CTEC or TSTL?

Is CTEC or TSTL a better dividend stock?

Is CTEC or TSTL more profitable?

Do institutionals & insiders hold more shares of CTEC or TSTL?

Do analysts prefer CTEC or TSTL?

Does the media prefer CTEC or TSTL?

Summary

How does ConvaTec Group compare to EKF Diagnostics?

Does the media prefer CTEC or EKF?

Do analysts prefer CTEC or EKF?

Is CTEC or EKF more profitable?

Which has better valuation & earnings, CTEC or EKF?

Do insiders and institutionals have more ownership in CTEC or EKF?

Which has more volatility and risk, CTEC or EKF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEC vs. The Competition

ConvaTec Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools